We are live on ! Find out more

825 hedge funds and large institutions have $14.4B invested in Leidos in 2024 Q4 according to their latest regulatory filings, with 157 funds opening new positions, 310 increasing their positions, 259 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more first-time investments, than exits

New positions opened: 157 | Existing positions closed: 93

20% more repeat investments, than reductions

Existing positions increased: 310 | Existing positions reduced: 259

6% more funds holding

Funds holding: 777825 (+48)

0.86% less ownership

Funds ownership: 75.69%74.84% (-0.86%)

13% less capital invested

Capital invested by funds: $16.6B → $14.4B (-$2.18B)

35% less call options, than puts

Call options by funds: $71.8M | Put options by funds: $110M

36% less funds holding in top 10

Funds holding in top 10: 117 (-4)

Holders
825
Holders Change
+48
Holders Change %
+6.18%
% of All Funds
10.87%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.09%
New
157
Increased
310
Reduced
259
Closed
93
Calls
$71.8M
Puts
$110M
Net Calls
-$38M
Net Calls Change
-$67.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.23B +$14M +84,003 +0.5%
BlackRock
2
BlackRock
New York
$1.78B +$746K +4,481 +0%
State Street
3
State Street
Massachusetts
$845M +$10.5M +63,209 +1%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$488M +$4.56M +27,410 +0.8%
Boston Partners
5
Boston Partners
Massachusetts
$459M -$131M -788,847 -20%
JP Morgan Chase
6
JP Morgan Chase
New York
$456M -$56.4M -338,820 -10%
Invesco
7
Invesco
Georgia
$379M +$114M +682,532 +35%
First Trust Advisors
8
First Trust Advisors
Illinois
$274M +$25.9M +155,481 +9%
Norges Bank
9
Norges Bank
Norway
$266M +$26.6M +159,827 +9%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$261M -$98.3M -590,568 -25%
Massachusetts Financial Services
11
Massachusetts Financial Services
Massachusetts
$259M -$58.8M -353,650 -16%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$246M +$21.9M +131,832 +8%
Morgan Stanley
13
Morgan Stanley
New York
$209M +$27.1M +162,969 +13%
Northern Trust
14
Northern Trust
Illinois
$174M +$3.85M +23,153 +2%
AQR Capital Management
15
AQR Capital Management
Connecticut
$164M -$14.2M -85,172 -7%
Goldman Sachs
16
Goldman Sachs
New York
$151M +$33.7M +202,305 +24%
AllianceBernstein
17
AllianceBernstein
Tennessee
$144M +$139M +835,930 +511%
Legal & General Group
18
Legal & General Group
United Kingdom
$125M +$14.1M +84,894 +11%
VanEck Associates
19
VanEck Associates
New York
$121M +$39.9M +239,846 +40%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$121M -$14.8M -88,818 -10%
Charles Schwab
21
Charles Schwab
California
$121M -$7.47M -44,871 -5%
Mariner
22
Mariner
Kansas
$114M +$5.99M +35,992 +5%
UBS AM
23
UBS AM
Illinois
$111M -$6.05M -36,389 -5%
Arrowstreet Capital
24
Arrowstreet Capital
Massachusetts
$111M -$3.4M -20,413 -3%
PAM
25
Panagora Asset Management
Massachusetts
$100M -$6.2M -37,262 -5%

LDOS Hedge Fund Activity: Q4 2024 in Review

825 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Leidos (LDOS) for Q4 2024, worth a combined $14.4B — down 13% from $16.6B a quarter earlier.

Buyers outnumbered sellers: 157 funds opened new LDOS positions and 93 closed out — a net gain of 64 holders — while 310 added to existing stakes and 259 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $139M. The largest seller was Victory Capital Management, cutting an estimated $396M.

  • 825 institutional investors held Leidos (LDOS) as of Q4 2024, up from 777 in Q3 2024.
  • Funds reported $14.4B of Leidos stock for Q4 2024, down 13% quarter-over-quarter.
  • 157 funds opened new Leidos positions in Q4 2024 and 93 closed out, a net change of +64 holders.
  • The largest Leidos buyer in Q4 2024 was AllianceBernstein, an estimated $139M added.
  • The largest Leidos seller in Q4 2024 was Victory Capital Management, an estimated $396M sold.

Based on aggregated 13F filings for Q4 2024.